Targeting gene fusions in non-small cell lung cancer-a ceaseless success story?

被引:1
|
作者
Hydbring, Per [1 ]
机构
[1] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Non-small cell lung cancer (NSCLC); anaplastic lymphoma kinase (ALK); ROS proto-oncogene 1 (ROS1); rearranged during transfection proto-oncogene (RET); tyrosine kinase inhibitor (TKI); CRIZOTINIB; ALECTINIB;
D O I
10.21037/tlcr-23-284
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1358 / 1360
页数:3
相关论文
共 50 条
  • [41] Induction of apoptosis of non-small cell lung cancer by a methylated oligonucleotide targeting survivin gene
    H L Li
    A N Ma
    Cancer Gene Therapy, 2010, 17 : 441 - 446
  • [42] The role of immunotherapy in neoadjuvant treatment of non-small cell lung cancer-a narrative review
    Seiwerth, Fran
    Bitar, Lela
    Knezevic, Jelena
    Madzarac, Goran
    Samarzija, Miroslav
    Jakopovic, Marko
    AME SURGICAL JOURNAL, 2023, 3
  • [43] Treatment of Advanced Non-Small Cell Lung Cancer with RET Fusions: Reality and Hopes
    Rocco, Danilo
    Sapio, Luigi
    Della Gravara, Luigi
    Naviglio, Silvio
    Gridelli, Cesare
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [44] Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review
    Nagasaka, Misako
    Sexton, Rachel
    Alhasan, Roba
    Rahman, Sarah
    Asfar, Azmi S.
    Sukari, Ammar
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 145
  • [45] Prevalence of Thromboembolic Events in Patients With Non-Small Cell Lung Cancer and RET Fusions
    Aldea, Mihaela
    Marinello, Arianna
    Guyon, David
    Gazzah, Anas
    Barlesi, Fabrice
    Planchard, David
    Besse, Benjamin
    JAMA ONCOLOGY, 2023, 9 (11) : 1583 - 1584
  • [46] Targeting Hypoxia to Improve Non-Small Cell Lung Cancer Outcome
    Salem, Ahmed
    Asselin, Marie-Claude
    Reymen, Bart
    Jackson, Alan
    Lambin, Philippe
    West, Catharine M. L.
    O'Connor, James P. B.
    Faivre-Finn, Corinne
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (01):
  • [47] Amivantamab: A New Hope in Targeting Non-small Cell Lung Cancer
    Billowria, Koushal
    Das Gupta, Ghanshyam
    Chawla, Pooja A.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (02) : 124 - 141
  • [48] Targeting blood vessels for the treatment of non-small cell lung cancer
    Amir, Ethan
    Hughes, Sarah
    Blackhall, Fiona
    Thatcher, Nick
    Ostoros, Gyula
    Timar, Jozsef
    Tovari, Jozsef
    Kovacs, Gabor
    Dome, Balazs
    CURRENT CANCER DRUG TARGETS, 2008, 8 (05) : 392 - 403
  • [49] Targeting novel and established therapies for non-small cell lung cancer
    Spicer, James
    Chowdhury, Simon
    Harper, Peter
    CANCER LETTERS, 2007, 250 (01) : 9 - 16
  • [50] Targeting glycolysis in non-small cell lung cancer: Promises and challenges
    Xu, Jia-Qi
    Fu, Yan-Li
    Zhang, Jing
    Zhang, Kai-Yu
    Ma, Jie
    Tang, Jing-Yi
    Zhang, Zhi-Wei
    Zhou, Zhong-Yan
    FRONTIERS IN PHARMACOLOGY, 2022, 13